SCHEMBL4358649

SCHEMBL4358649

CC12CN(C(=O)CCl)CC(C)(CN(C(=O)CCl)C1)C2=O

nearest known ligand 0.59

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.56
POLB P06746 4/20 0.54
ALDH1A1 P00352 6/20 0.46
GAA P10253 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
HTT P42858 1/20 0.39
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11837217 0.79 ALDH1A1 (0.52) ALOX15POLBALDH1A1SMN1; SMN2HTT
SCHEMBL16083089 0.77 ALDH1A1 (0.50) ALOX15POLBALDH1A1SMN1; SMN2HTT
SCHEMBL18956020 0.75 ALDH1A1 (0.48) ALOX15POLBALDH1A1SMN1; SMN2KMT2A
SCHEMBL8905148 0.75 ALDH1A1 (0.48) ALOX15POLBALDH1A1SMN1; SMN2HTT
SCHEMBL27012291 0.73 ALDH1A1 (0.50) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL20547329 0.73 ALDH1A1 (0.50) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL24414321 0.72 ALDH1A1 (0.48) POLBALDH1A1SMN1; SMN2HTTLMNA
SCHEMBL5100930 0.70 ALDH1A1 (0.47) POLBALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL16083080 0.70 ALDH1A1 (0.47) POLBALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL30459460 0.68 ALDH1A1 (0.41) POLBALDH1A1SMN1; SMN2KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021004-A1 3,6,9-TRIAZATRICYCLOTETRADECANE DERIVATIVE AND USE THEREOF FOR TREATING DEPRESSION Общество с ограниченной ответственностью "Кью Эм Фарма" 2021-02-04 WO disclosed
EP-2088149-A1 PHARMACOLOGICALLY ACTIVE N,N'-SUBSTITUTED 3,7-DIAZABICYCLO Ý3.3.1¨NONANES, PHARMACEUTICAL COMPOSITIONS BASED THEREON AND A METHOD FOR THE USE THEREOF Institute of Physiologically active compunds of the Russian Academy of Sciences (IPAC RAN) (RU) 2009-08-12 EP disclosed